Background The COPD Assessment Test (CAT) is responsive to change in patients with chronic obstructive pulmonary disease (COPD). However, the minimum clinically important diff erence (MCID) has not been established. We aimed to identify the MCID for the CAT using anchor-based and distribution-based methods.
Introduction
The COPD Assessment Test (CAT) is a simple, eight item, health status instrument for patients with chronic obstructive pulmonary disease (COPD), which is highly practical, 1 has good psychometric properties, and has been shown to be responsive to pulmonary rehabilitation and recovery from exacerbation. [2] [3] [4] [5] [6] [7] [8] A decrease in CAT score represents an improvement in health status, whereas an increase in CAT score represents a worsening in health status. The CAT has been incorporated into the Global Initiative for Chronic Obstructive Lung Disease (GOLD) combined assessment of COPD as a means of establishing a symptomatic threshold to guide initiation of regular pharmacological treatment. 9 Because it takes only 2-3 min to complete, the CAT has practical advantages over longerestablished health status questionnaires such as the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Questionnaire (CRQ).
The minimum clinically important diff erence (MCID) is the smallest change in score that patients perceive as benefi cial or detrimental, and is useful to aid the clinical interpretation of health status data, particularly in response to intervention. By contrast with other health status questionnaires commonly used in COPD such as the SGRQ and CRQ, [10] [11] [12] to our knowledge the MCID of the CAT has not been described.
We aimed to estimate the MCID for the CAT using a range of anchor-based and distribution-based methods in three diff erent clinical scenarios: response to pulmonary rehabilitation, recovery after admission to hospital for acute exacerbation of COPD, and longitudinal change with time. We postulated that the CAT score would improve with pulmonary rehabilitation and recovery from admission to hospital (ie, a decrease in CAT score), but worsen with time in stable patients (ie, an increase in CAT score), and that change in CAT score would correlate signifi cantly with change in other well-established COPD health status questionnaires.
Methods

Participants
In Study 1, we recruited stable patients with COPD from the Harefi eld Pulmonary Rehabilitation Unit (Harefi eld Hospital, London, UK). Inclusion criteria included a diagnosis of COPD, ability to walk 5 m, and no contraindication to exercise. 13 For Study 2, we recruited patients who had an acute exacerbation of COPD diagnosed by a physician and an admission longer than 24 h to acute wards at Hillingdon Hospital (London, UK). In Study 3, we recruited stable patients with COPD from outpatient clinics at Harefi eld Hospital; patients were deemed stable if they had not had an exacerbation in the 4 weeks before the baseline measurement. Patients were not excluded from Study 3 if they had an excerbation during the 12 month follow-up period. Age 35 years or older was an inclusion criterion for all studies. Patients unable to read or understand English were excluded from all studies. All participants gave written informed consent and all studies received local ethics committee approval.
Procedures
Study 1 assessed response of the CAT to pulmonary rehabilitation. We measured the CAT, SGRQ, and CRQ before and after an 8 week outpatient pulmonary rehabilitation programme, consisting of twice weekly supervised exercise and education sessions. 6, 12, 14 We measured the incremental shuttle walk, fi ve-repetition sit-to-stand, and 4 m gait speed to assess change in physical performance. [15] [16] [17] Patients were kept masked to their performance and were asked to rate their change in health status after pulmonary rehabilitation using an adapted fi ve point Global Rating of Change Questionnaire (GRCQ). 18 Patients were asked to classify how they felt after pulmonary rehabilitation according to fi ve responses: "1: much better"; "2: a little better"; "3: no change"; "4: a little worse" and "5: much worse". Data from 255 of the 565 patients in Study 1 have been used as a comparator group in a previous study. 19 Study 2 assessed change in CAT score after admission to hospital for acute exacerbation of COPD. Forced expiratory volume in one second (FEV 1 ), CAT, SGRQ, and 4 m gait speed were measured on the day of hospital discharge and about 3 months later.
Study 3 assessed longitudinal change in CAT score with time. Patients with COPD attending outpatient respiratory clinics were asked to complete FEV 1 , incremental shuttle walk, 4 m gait speed, CAT, and SGRQ, and again at 12 months.
Statistical analysis
Study 1 was a pragmatic observational study in which we aimed to prospectively recruit a minimum of 500 patients with paired CAT measurements. We anticipated 25% dropout on the basis of our experience with the pulmonary rehabilitation programme and therefore recruited 675 patients. For studies 2 and 3, 124 paired measurements were required to detect a correlation coeffi cient above 0·3 between change in CAT and change in anchor with 80% power at the 0·01 signifi cance level.
We anticipated a minimum dropout of 30% on the basis of data from other longitudinal cohorts, therefore we recruited 200 patients in each study. We did data analyses and graphical presentations using SPSS (version 21) and Prism (version 5). When estimating MCID in change in CAT score, only data from participants who completed paired CAT measurements were included for analysis. We used the paired t test to compare paired measurements. We used Pearson's correlation (in which the null hypothesis was defi ned as no correlation) and linear regression to compare change in CAT score with other outcome measurements.
Estimation of MCID
For anchor-based estimation of MCID, predefi ned criteria for establishing the validity of external anchors were: a signifi cant correlation between change in CAT score and change in anchor, and a correlation coeffi cient of more than 0·3 as previously recommended. 20 In Study 1, change in CAT score with pulmonary rehabilitation was anchored against change in SGRQ total score, CRQ total score, and CRQ domain scores. For the GRCQ, we calculated the mean (95% CI) change in CAT score with pulmonary rehabilitation in those reporting feeling "a little better". We did not include those reporting feeling "much better" because we believed that including these patients might lead to an overestimation of the MCID. In studies 2 and 3, change in CAT score was anchored against change in SGRQ.
In studies 1 and 2, the focus was to establish the minimum clinically important improvement because of the small numbers of patients reporting signifi cant worsening of health status. For MCID at the individual patient level, we used receiver operating characteristic curves. The change in CAT score cutoff that best discriminated between patients who improved their health status by the established MCID in the SGRQ total score (-4 point change) or CRQ total score (+10 point change) was defi ned as the MCID, with equal weighting given to sensitivity and specifi city. 10, 12 For MCID at the population level, we used linear regression analysis to estimate change in CAT score corresponding to the minimum clinically important improvement for the SGRQ and CRQ total scores, and CRQ domain scores (+2·5 dyspnoea, +2·0 fatigue, +3·5 emotion, +2·0 mastery). 10 In Study 3, because there were much the same numbers of patients showing improvement and worsening of health status, we applied receiver operating characteristic curves and linear regression to investigate both minimum clinically important improvement and deterioration.
For distribution-based methods, we calculated half the SD (0·5 SD) 21 and the SE of measurement (SEM), 22 given by the equation:
On the basis of previous data, we assumed the test-retest reliability of the CAT to be 0·8.
2,4
Role of the funding source
The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data in the study. WD-CM made the fi nal decision to submit for publication.
Results
Study 1 took place between April 1, 2010, and Dec 31, 2012. Of 675 patients with COPD referred for pulmonary rehabilitation, 565 (84%) completed pulmonary rehabilitation and had paired CAT results. The reasons for non-completion were exacerbation or admission to hospital (46 patients, 7%), poor adherence to pulmonary rehabilitation (29, 4%), work reasons (11, 2%), family illness (ten, 1%), holiday (seven, 1%), declined end of course assessment (four, 1%), and death (three, <1%). Baseline characteristics of the non-completers are shown in the appendix; patients who did not complete pulmonary rehabilitation had signifi cantly worse baseline health status as determined by their SGRQ Impact and CRQ total scores. Table 1 shows the baseline characteristics of the completers, and the changes in health status and physical performance with pulmonary rehabilitation. Mean change in CAT with pulmonary rehabilitation was -2·5 (95% CI -3·0 to -1·9). Table 2 shows the slope, y intercept, and correlation coeffi cient between change in CAT score and change in other outcome measures. Only change in SGRQ total and change in CRQ total and CRQ domain scores correlated with change in CAT score with a correlation coeffi cient greater than 0·3 (fi gure 1). Figure 2 shows the receiver operating characteristic curves for change in CAT in identifying patients who improved their SGRQ and CRQ total scores by more than the established MCID. Both curves were consistent in identifying -2 as the best discriminating CAT change cutoff with an area under the curve C statistic of 0·65 for SGRQ and 0·70 for CRQ. The appendix shows the sensitivity and specifi city for alternative estimates of the minimum clinically important improvement in CAT score.
With linear regression, by use of a change in CRQ total score of +10 as the cutoff for minimum clinically important improvement, the estimated minimum clinically important improvement in CAT score was -1·8 (95% CI -2·6 to -1·0). By use of the established MCID for the CRQ domains as cutoff s, the estimates for minimum clinically important improvement in CAT score were -1·7 (95% CI -2·5 to -1·0) for dyspnoea, -2·0 (-2·7 to -1·2) for fatigue, -2·3 (-3·0 to -1·5) for emotion, and -2·2 (-2·9 to -1·5) for mastery. With SGRQ total change of -4 as the cutoff , the estimated minimum clinically important improvement for CAT score was -2·3 (95% CI -2·7 to -1·8). There were few patients reporting signifi cant worsening in health status 
Data are mean (95% CI) or n (%) unless otherwise specifi ed. See Online for appendix (fi gure 1); comparison of the slopes of CAT score against CRQ and SGRQ scores in patients who improved and those who deteriorated showed no signifi cant diff erence (ANCOVA p=0·67 and p=0·99, respectively).
With the GRCQ, 299 of 565 (53%) patients reported feeling much better, 209 (37%) patients reported feeling a little better, 40 (7%) patients reported no change, and 17 (3%) patients reported feeling a little or much worse. The mean change in CAT score in those reporting feeling "a little better" after pulmonary rehabilitation was -1·6 (95% CI -2·6 to -0·8). For those feeling "much better", the mean change in CAT score was -3·2 (95% CI -4·0 to -2·5).
With distribution-based methods, the estimate for signifi cant improvement in CAT score using 0·5 SD was -3·8 and using SEM was -3·3.
Study 2 took place between Nov 16, 2011, and Dec 31, 2012. Of 200 patients with acute exacerbations of COPD recruited, 147 (74%) had paired CAT measurements. Reasons for dropout were death (14 patients, 7%), declined attendance (26, 13%), acutely unwell in hospital (ten, 5%), and moved out of area (three, 2%). The mean duration between baseline (discharge from hospital) and follow-up measurement was 90·2 days (SD 7·7; range 79-102). The appendix shows baseline characteristics of patients who did not attend follow-up; baseline characteristics of those who attended follow-up and those who did not attend did not diff er. Table 3 shows clinical characteristics of this group and the change in outcomes after hospital discharge. Mean CAT score at hospital discharge (23·5 [95% CI 22·3-24·8]) was signifi cantly higher than baseline CAT score in patients referred for pulmonary rehabilitation in Study 1 (21·4 [20·8 to 22·0]) and stable outpatients in Study 3 (20·1 [19·1 to 21·2]; ANOVA p=0·0002).
Mean change in CAT score from hospital discharge to 3 months after discharge was -3·0 (95% CI -4·4 to -1·6). Change in CAT score correlated signifi cantly with change in SGRQ (r=0·47; p<0·0001; fi gure 3) and change in FEV 1 (r=-0·26; p=0·0021), but not change in 4 m gait speed (r=-0·10; p=0·24). By use of receiver operating characteristic curves, a -2 change in CAT score best discriminated patients who improved by the MCID or more in SGRQ (n=84) with an area under the curve C statistic of 0·66. Sensitivity and specifi city data for alternative estimates are in the appendix. Linear regression analysis, using an SGRQ change of -4 as the cutoff , estimated the minimum clinically important improvement of the CAT as -2·8 (95% CI -3·7 to -1·9). The slopes of CAT against SGRQ in patients who improved and in those who deteriorated were not signifi cantly diff erent (ANCOVA p=0·21).
With distribution-based methods, the estimate for signifi cant improvement in CAT score using 0·5 SD was -3·7 and using SEM was -3·3.
Study 3 recruited between Jan 1, 2012, and Aug 31, 2012. Of 200 stable patients recruited, 164 (82%) returned for measurements 12 months later. Reasons for dropout included: death (six patients, 3%), current admission to hospital for exacerbation (seven, 4%), current admission to hospital for another reason (four, 2%), declined (ten, 5%), unable to contact (six, 3%), and moved out of area (three, 2%). The mean duration between baseline and follow-up measurement was 364·6 days (SD 20·7, range 332-401 days). The appendix shows baseline characteristics of patients who did not attend follow-up; patients who did not attend follow-up were younger and had better CAT scores than those who attended follow-up. Table 4 shows clinical characteristics of this cohort and change in FEV 1 , incremental shuttle walk, 4 m gait speed, CAT, and SGRQ with time. There was no signifi cant change in CAT over time, but change in CAT correlated signifi cantly with change in SGRQ (r=0·36; p<0·0001; fi gure 4), incremental shuttle walk (r=-0·25; p=0·0005), and 4 m gait speed (r=-0·18; p=0·0142). For those who improved their SGRQ (n=64), the receiver operating characteristic curve showed that a -1 point change in CAT score was the best discriminant with an area under the curve C statistic of 0·66, and that a +1 point change in CAT score best identifi ed those who had a clinically signifi cant worsening in health status as measured by the SGRQ (n=51) with an area under the curve C statistic of 0·69. With SGRQ change of -4 as an anchor, linear regression analysis estimated the minimum important improvement in CAT score as -1·2 (95% CI -2·5 to -0·0). The slopes of CAT score against SGRQ score in patients who improved and those who deteriorated were not signifi cantly diff erent (ANCOVA p=0·20). With distribution-based methods, the estimate for signifi cant improvement in the CAT score using 0·5 SD was 3·8 and using SEM was 3·4. Table 5 summarises all estimates for the MCID for the CAT.
Discussion
Our studies show that the CAT is responsive to change after pulmonary rehabilitation and recovery from hospital admission for acute exacerbation of COPD, and that change in CAT correlates signifi cantly with change in other health status measures and physical performance measures. Furthermore, as far as we are aware, these studies are the fi rst to prospectively and purposively estimate the MCID for the CAT. With anchors measuring similar constructs in diff erent cohorts, the estimates for the minimum important improvement in CAT score ranged from -1·2 to -2·8 with -2 being the most consistent estimate from sensitivity and specifi city analyses.
Health status is recommended as an essential outcome measure by pulmonary rehabilitation guidelines. 23 As far as we are aware, Study 1 was the largest study so far to use the CAT during pulmonary rehabilitation (panel). We showed longitudinal validity of the CAT by identifying signifi cant correlations between change in CAT and change in SGRQ, CRQ, and physical performance measures. We recorded a mean change in CAT score of -2·5 with an 8 week outpatient pulmonary rehabilitation programme, in line with previous studies from the UK and the USA and Canada. 3, 7 The CAT has also been studied in an unselected chronic respiratory disease population undergoing pulmonary rehabilitation, with 110 non-COPD patients showing a mean CAT change of -2·1, much the same as the mean change measured in patients with COPD. 19 Several studies have used the CAT as a measure of health status during hospital and community-based treatment of acute exacerbations of COPD, showing changes in CAT ranging from -1·4 to -9·9. 4 ,5 Study 2 focused exclusively on recovery of the CAT score after admission to hospital, with the baseline CAT measured on the day of hospital discharge. The recorded mean Table 5 : Anchor-based and distribution-based estimates of the MCID of the CAT in the three studies change in CAT was -3·0, and this outcome correlated signifi cantly with change in SGRQ (r=0·47). This fi nding could have implications when designing clinical intervention trials in the period after admission to hospital, particularly with regard to sample size calculation. Until now, there have been few data regarding longitudinal change in CAT with time. In the original description of the CAT, test-retest reproducibility over 7 days was good (intraclass correlation coeffi cient 0·8), while in stable patients over 4 weeks, the CAT showed a test-retest intraclass correlation coeffi cient of 0·83. 2, 4 Over a 6 month period, Dodd and colleagues 6 showed an increase in CAT from 19·2 to 20·7, although importantly, baseline measurements were recorded immediately after completion of a pulmonary rehabilitation programme. We recorded paired measurements 12 months apart. Our prespecifi ed hypothesis that health status would deteriorate signifi cantly over 12 months (ie, increase in CAT score) was not supported by our data, although deteriorating health status, including death, was a reason for loss to follow-up. Although the 12 month recall rate was good (higher than 80%), there was likely to be an element of selection bias in that paired CAT scores were not obtained in those who had died or were receiving inpatient treatment at the recall timepoint. Nevertheless, it was reassuring to show that change in the CAT correlated signifi cantly with change in SGRQ and physical performance measures over 12 months.
The determination of the MCID remains controversial with no fi rm consensus, but is important in the validation of clinical instruments and the assessment of clinical studies. Two main approaches are generally used: anchor and distribution-based methods. Anchor-based methods rely on comparison of the change in outcome of interest with another outcome measure of change, known as the anchor or external criterion. However, this comparison is only relevant if there is an established association between the outcome of interest and the anchor. No consensus exists regarding the threshold strength of the association: some investigators have suggested an arbitrary minimum correlation coeffi cient of greater than 0·50, although others have suggested 0·30. 11, 20 Although cross-sectional studies have shown strong correlations of the CAT and SGRQ, with four units on the SGRQ corresponding to 1·6 on the CAT, this association might diff er when assessing change in these instruments. 26 The MCID is most useful for clinicians or researchers in the "change" setting, and therefore we made great eff orts to assess change in CAT in three independent cohorts, including longitudinal follow-up. The candidate anchors with strongest correlations were COPD-specifi c health status questionnaires (CRQ and SGRQ), presumably because these instruments measure similar constructs to the CAT, with correlation coeffi cients ranging from 0·32 to 0·47. Previous guidance has recommended the use of several approaches and triangulation of methods. 20 We used several anchors, adopted diff erent methods of anchor-based estimations (linear regression analysis, sensitivity and specifi city analysis using receiver operating characteristic curves), and presented change in CAT in three diff erent clinical scenarios to provide clinical context.
The estimates of the MCID of the CAT were consistent across diff erent cohorts in diff erent scenarios over diff erent timeframes (table 5) , providing some degree of corroboration and credibility, although the correlations with the external anchors were only moderate and caution is needed in the interpretation. At the individual level (the CAT score permits only integers), the ROC analysis and the anchor responses to the GRCQ estimated the MCID to be -2. From the linear regression analysis, the population-level MCID estimates ranged from -1·2 to -2·8, with the mean of these estimates being -2·0. Therefore, both the population-level estimate (used to assess group eff ects of treatments or diff erences between populations) and the individual patient-level estimate (used for responder analysis) was -2.
Anchor-based methods to estimate MCID are often preferred to distribution-based approaches because they take into account patient-reported benefi t or deterioration. However, there are limitations. As mentioned previously, anchor-derived estimates are only valid if the outcome of interest correlates with the anchor. Any patient-reported outcome recorded before and after a period of time is also subject to recall bias. Anchors are designed to detect change in outcome but rarely take into account costs to the
Panel: Research in context
Systematic review
We searched PubMed for studies in English focusing on estimates of the minimum clinically important diff erence (MCID) of the COPD Assessment Test (CAT) from inception, to Oct 21, 2013 . We used the terms "MID" or "minimal important diff erence" or "minimum important diff erence" or "MCID" or "minimal clinically important diff erence" and "CAT" or "COPD Assessment Test" or "Chronic Obstructive Pulmonary Disease Assessment Test". We identifi ed three studies 7, 24, 25 that provided estimates of the MCID of the CAT, although through retrospective opportunistic post-hoc analyses. These studies looked at improvement in stable populations using only one methodological approach for estimation; the resulting estimates ranged from a -1·3 to -3·76 point change.
Interpretation
As far as we are aware, this is the fi rst report to provide prospective data to estimate the MCID of the CAT. Our studies provide 19 separate estimates of the MCID using both distribution-based and anchor-based methods, from three separate clinically relevant cohorts, including stable patients having pulmonary rehabilitation and longitudinal follow-up, and also in those recovering from exacerbation. To our knowledge, Study 1 is the largest study using the CAT in pulmonary rehabilitation. Our fi ndings suggest that a decrease in CAT of 2 points is the most reliable estimate of the MCID at the individual and population level. This estimate will allow clinicians to interpret clinically important change in individual patients, and help researchers with sample size calculations and the interpretation of CAT data in response to intervention studies.
patient, for example side-eff ects of therapy. Another limitation is that changes in an outcome measure might be associated with baseline level. Potential reasons for this association include so-called fl oor and ceiling eff ects. The CAT score ranges from 0 to 40 with a decrease in score showing improvement in health status. At extreme values (eg, a baseline CAT of 0), the instrument cannot detect an improvement in health status. Similarly, if the baseline CAT is 40, there is no room for further worsening in health status. Although we used three independent cohorts of patients with COPD, with varying baseline mean values, these were generally recruited from a secondary care setting. The present studies cannot address whether our estimates of MCID for the CAT hold true in populations at extremes of the health spectrum (for example, communitydwelling asymptomatic patients with COPD, or highly symptomatic patients receiving palliative care).
To provide a comprehensive approach, we also used distribution-based methods to estimate the MCID of the CAT. Distribution-based approaches use statistical methods, and are based on the distribution of the cohort and the reliability of the measure; as such they do not take into account whether the recorded change is important from the patient's perspective. Previous investigators have noted that 0·5 SD and the SEM might approximate the MCID in some patient-reported outcome measures, 21, 22 although other measures have also been described including 1·96 SEM and minimum detectable change; depending on which distribution-based approach is used, a range of diff erent estimates of the MCID can be generated which might signifi cantly limit their interpretation. 27 Another specifi c limitation to the present studies was that the test-retest reliability of the CAT was assumed on the basis of previous studies of much shorter duration. Our estimates of the MCID for the CAT, using 0·5 SD and SEM, were consistent across the three clinical scenarios, suggesting that the distributions of our three cohorts were much the same. However, it was also noticeable that the distribution-based methods consistently estimated the MCID to be greater than the anchor-based estimates, suggesting that the CAT had a wide distribution in our cohorts. This situation is not unique in patients with COPD. For example, Puhan and colleagues 28 showed that the MCID for maximal cycle exercise capacity ranged from 2·2 W to 3·3 W, whereas distribution-based estimates were 5·3-5·5 W. 28 Although we provide data from both approaches we have chosen to place greater emphasis on the anchorbased estimates for two reasons. First, although distribution-based estimates provide supportive information regarding a signifi cant change, they do not provide a direct measure of minimum clinical importance, a view shared by other researchers. 28, 29 Second, the MCIDs estimated by distribution-based methods were greater than the mean change identifi ed after pulmonary rehabilitation, widely accepted as a highly eff ective intervention that signifi cantly improves health-related quality of life in COPD, and the mean change identifi ed during recovery after admission to hospital for severe exacerbation of COPD. In view of these clinical contexts, we believe the data derived from distribution-based methods provide information about clinical signifi cance but might overestimate the true MCID.
In the present studies, our focus was on establishing the minimum clinically important improvement. In studies 1 and 2, the number of patients with improving health status far outweighed those who had worsening health status (90% vs 3% according to the GRCQ), and we did not report estimates of minimum important clinical deterioration for fear of imprecision. We believe that the magnitude of the minimum clinically important deterioration is likely to be much the same as for improvement. For example, when we compared the linear regression slopes of those who improved and deteriorated according to their anchor, we identifi ed no signifi cant diff erence. In Study 3, in which there were more equivalent numbers of patients improving and worsening their health status, the receiver operating characteristic curves estimated similar magnitude cutoff s. Further studies focusing on worsening health status are needed to confi rm whether patients perceive size of deterioration diff erently to size of improvement.
The main aim of the present studies was to estimate the MCID in change in CAT, and hence paired measurements were used for the analyses. In all three studies, there were missing data (usually because of exacerbation) and it could be argued that these missing data might bias our estimates of the MCID. If a patient deteriorated because of exacerbation or admission to hospital, we would expect not only the CAT to worsen but also the external anchors. Because there was no diff erence in the slopes of change in patients who improved compared with those who deteriorated, we do not believe that missing data were a signifi cant source of bias in our estimates of the MCID for the CAT.
In summary, the present studies show that the CAT is responsive to the eff ects of pulmonary rehabilitation and recovery from admission to hospital for acute exacerbation of COPD. By use of various health status and global rating of change questionnaires as external anchors, we estimate the minimum important improvement of the CAT to be a two point decrease at both the individual and population level. This information could be useful in the clinical interpretation of CAT data, particularly in response to intervention studies.
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